CoChat

Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions

Dale, Roman M., Bryant, Kelly A., Thompson, Nicolas R. · 2020 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Purpose There is a practical need for the identification of pretreatment clinical and epidemiological response predictors to repeat ketamine infusions. Response predictors can serve to guide clinical inclusion of patients and weigh risks versus benefits for those receiving maintenance ketamine. Previous studies indicate a link between obesity, depression, and treatment response. We sought to investigate if body mass index (BMI) or metabolic syndrome could predict treatment response to ketamine. Methods Patients aged 18 to 72 years who were electroconvulsive therapy nonresponders were given a subanesthetic ketamine hydrochloride dose of 0.5 mg/kg delivered intravenously for 40 minutes for an acute series of 3 to 6 infusions every other day. If patients reported at least a 50% decrease in depression symptoms after the acute series, they were moved to a maintenance series of infusions, on an individualized basis. To assess if BMI or metabolic syndrome could predict response, logistic regression models were run to analyze initial responders, sustained responders, and nonresponders. Models were adjusted for age, sex, and baseline depression severity. Results Of the 150 patients analyzed, 56 did not respond to the acute phase, 38 initially responded to the acute phase but relapsed during the maintenance phase, and 56 sustained their response for 1 year. In unadjusted models, BMI was not shown to be a predictor of initial or sustained response. Alternatively, metabolic syndrome defi…

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0000000000001149

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Cited by

See all 33

Metadata

Authors
Dale, R. M., Bryant, K. A., & Thompson, N. R.
Affiliations
Cleveland Clinic (US)
Venue
Journal of Clinical Psychopharmacology
Published
2019-12-11
Volume
40
Issue
1
Pages
75-79
ISSN
  • 0271-0749 (ISSN-L)
  • 1533-712X
OpenAlex
W2996714229
Cited by
29
References
40
Citations by year
2026: 3 · 2025: 7 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 4 · 2020: 5
FWCI
2.17
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords
ketamine, metabolic syndrome, body mass index, obesity, depression, treatment response prediction, hypertension, hyperlipidemia, hyperglycemia, relapse
MeSH terms
Adolescent, Adult, Affect, Aged, Antidepressive Agents, Drug Administration Schedule, Female, Humans, Infusions, Intravenous, Ketamine, Male, Middle Aged, Obesity, Registries, Time Factors, Body Mass Index, Treatment Outcome, Metabolic Syndrome, Young Adult, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions. https://app.cochat.ai/papers/10.1097/jcp.0000000000001149
The paper
Dale, R. M., Bryant, K. A., & Thompson, N. R. (2020). Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000001149

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.